- Pandemic Ethics and Status Quo Risk.Richard Yetter Chappell - 2022 - Public Health Ethics 15 (1):64-73.details
|
|
Allocating Remdesivir Under Scarcity: Social Justice or More Systemic Racism.Eli Weber & Mark J. Bliton - 2020 - American Journal of Bioethics 20 (9):31-33.details
|
|
Decisions on Innovation or Research for Devastating Disease.M. H. Andreae, L. D. Shah, V. Shepherd, M. Sheehan, H. S. Sacks & R. Rhodes - 2021 - American Journal of Bioethics 21 (12):28-31.details
|
|
Guiding Difficult Decisions on Scarce Investigational Therapeutic Agents in the COVID-19 Pandemic.Keith W. Hamilton - 2020 - American Journal of Bioethics 20 (9):20-23.details
|
|
Physicians’ Ethical and Professional Obligations about Right-to-Try Amidst a Pandemic.Zubin Master & Jon Tilburt - 2020 - American Journal of Bioethics 20 (9):26-28.details
|
|
How to Be Fair, and Power Research? Select Patients by Flipping a Coin.Tom Tomlinson - 2020 - American Journal of Bioethics 20 (9):29-31.details
|
|
The Inherent Unfairness of COVID-19 Drug Access Pathways.Kayte Spector-Bagdady, Misty Gravelin, Kevin J. Weatherwax & Andrew G. Shuman - 2020 - American Journal of Bioethics 20 (9):18-20.details
|
|
Allocating scarce unproven interventions during public health emergencies: Insights from the who meuri framework.Ignacio Mastroleo & Maxwell J. Smith - 2020 - American Journal of Bioethics 20 (9):41-44.details
|
|
Fairness and Protection for the Vulnerable: Lessons from Esketamine.Gin S. Malhi & Julian Savulescu - 2020 - American Journal of Bioethics 20 (9):36-38.details
|
|
The Limits of Individualism: Potential Societal Harms from the EAP for Convalescent Plasma.David Magnus - 2020 - American Journal of Bioethics 20 (9):1-3.details
|
|
Physician Responsibility to Discuss Palliative Unproven Therapies With Out-of-Option Patients.Omar Kawam, Jon C. Tilburt & Zubin Master - 2021 - American Journal of Bioethics 21 (12):31-33.details
|
|
Adopting an Anti-Racist Model of COVID-19 Drug Allocation and Prioritization.Akilah A. Jefferson - 2020 - American Journal of Bioethics 20 (9):33-36.details
|
|
The Decision to Enroll in a Clinical Trial Should Be Unencumbered.Luke Gelinas & Barbara E. Bierer - 2020 - American Journal of Bioethics 20 (9):23-25.details
|
|
The Case for Methodological Pluralism in Medical Science.Sarah J. L. Edwards, Thomas Bock, Ulo Palm, Sally Wang, Glen Cheng, Lixia Wang & Peter Pitts - 2020 - American Journal of Bioethics 20 (9):39-41.details
|
|